Edition:
United States

People: Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

76.70EUR
27 Jul 2016
Change (% chg)

-- (--)
Prev Close
€76.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,729,705
52-wk High
€101.10
52-wk Low
€62.50

Bicker, Uwe 

Mr. Uwe Bicker has been Independent Director of Sanofi SA since May 14, 2008. He is also Member of the Strategy Committee of the Company. Additionally, he serves as Member of the Supervisory Board of Foundation Aventis and of Future Capital AG, as well as Member of the Consulting Committee of Morgan Stanley. As of 2011, he has been the Dean at the Medical Faculty of the Heidelberg University, where he has been Professor since 1983, and he also became Managing Director at the University Clinic of Mannheim in 2011. He is also an Honorary Senator of Heidelberg University and an Honorary Doctor of the Klausenburg University. During his professional career, Mr. Bicker was also appointed as Trustee of Fondation Aventis. Between 1975 and 1994, he held various positions at Boehringer Mannheim GmbH (later Roche AG) and from 1994 to 2004, he held various positions at Hoechst group. Until 2012, Mr. Bicker also served as Chairman of the Supervisory Board of Siemens Healthcare Diagnostics Holding GmbH, Vice Chairman of the Supervisory Board of Epigenomics AG and of Definiens AG. He is a Physician and holds a Doctorate in Chemistry and Medicine.

Basic Compensation

Total Annual Compensation, EUR 119,500
Restricted Stock Awards, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR --
Fiscal Year Total, EUR 119,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --